Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 29 member 4 pseudogene 1 (SLC29A4P1) is classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene (in this case, SLC29A4, which encodes a nucleoside transporter) but has lost its protein-coding ability due to mutations or deletions and does not produce a functional protein[2][6]. Pseudogenes are typically non-functional genomic elements, though they may play regulatory roles in rare cases. There is no evidence or documentation supporting SLC29A4P1 as a therapeutic target, biomarker, or drug interaction site. All available data point to this gene being a non-coding pseudogene with no direct biological, therapeutic, or disease relevance in terms of molecular targeting[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 29 member 4 pseudogene 1 (SLC29A4P1).